Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The participants were divided into the following experimental groups or a placebo group: 1 mg of retatrutide (subcutaneously) 4 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg 4 mg of retatrutide (subcutaneously), starting at an initial dose of 4 mg 8 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg 8 mg of retatrutide (subcutaneously), starting at an initial dose of 4 mg 12 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg Here are the detailed results of the trial at 24 weeks and 48 weeks: Phase II clinical trial projects promising results of retatrutide in weight management
None of the retatrutide combinations on this page has established dosing, interaction, long-term safety, or outcome data from a controlled human trial
Some research-grade peptides arrive in nitrogen-flushed vials, and maintaining this atmosphere during storage extends room temperature viability
Rare contact dermatitis has been reported with topical copper peptide products
US$ 29.92
US$ 22.82
US$ 29.00
US$ 21.83
US$ 23.91
